Chronic Migraine — When Headache Becomes Your Everyday Life

The medical definition of chronic migraine is specific: headache on 15 or more days per month, for at least 3 consecutive months, with at least 8 of those days meeting criteria for migraine. This definition matters because it separates chronic migraine from other forms of chronic daily headache, which have different causes and treatments.

Episodic migraine — the more familiar form — means attacks that come and go, with clear pain-free periods in between. Most people with episodic migraine have fewer than 8 attacks per month, and their baseline (between attacks) is normal.

In chronic migraine, the boundary between "attack" and "not having an attack" blurs. Many patients describe waking up with a dull, heavy head most mornings, which some days stays at a low level and some days escalates into a full migraine attack. There is no clean baseline anymore — the nervous system is in a state of near-constant low-level sensitisation.

How common is it?

About 2–3% of the general population has chronic migraine — roughly 1 in 40 people. But within migraine populations, roughly 8% of episodic migraine patients convert to chronic migraine per year. This makes it a significant and largely under-treated condition.

What it does to quality of life:

Chronic migraine is not just more frequent headaches — it is a different life. Work attendance and performance suffer. Social commitments become unreliable. Sleep is poor, anxiety increases, and many patients develop depression — not as a cause, but as a consequence of living with near-daily pain. Studies consistently show that chronic migraine has a greater impact on quality of life than most other neurological conditions, including epilepsy.

An important distinction: New Daily Persistent Headache (NDPH)

Some patients develop daily headache suddenly — they remember the exact day it started and it never went away. This is NDPH, a different condition that requires separate evaluation. Chronic migraine, in contrast, develops gradually from episodic migraine over months to years.

Understanding the transformation from episodic to chronic migraine requires one concept: central sensitisation.

In episodic migraine, the nervous system is triggered by specific factors (hormones, sleep changes, certain foods, stress), generates an attack, and then returns to its baseline. The "off switch" works.

With repeated attacks over time — especially if they are frequent, severe, or poorly treated — something changes in the central nervous system itself. The pain-processing pathways in the brain and spinal cord become progressively sensitised. They start amplifying pain signals. The threshold for triggering a migraine drops lower and lower. Eventually, things that never triggered a migraine before — mild stress, a glass of wine, a slightly disrupted sleep — now reliably produce an attack. And the attacks start coming more and more often.

This is central sensitisation — the brain's pain system is now chronically in a lower-threshold, higher-gain state. It is not a psychological problem; it is a measurable neurological change. Functional MRI studies show physical differences in the way the brains of chronic migraine patients process pain compared to episodic migraine patients.

The key physiological changes:

What accelerates the transition:

Research has identified specific risk factors that speed up conversion from episodic to chronic migraine:

This is the most important section in this guide for many readers — and the hardest one to accept.

If you take headache medicine — any headache medicine: paracetamol, ibuprofen, aspirin, Saridon, Combiflam, triptans (sumatriptan), or ergotamines — on 10 or more days per month, the medicine itself begins to cause headaches. This condition is called Medication Overuse Headache (MOH), and it affects a large proportion of people with chronic daily headache.

How it works physiologically:

Repeated exposure to acute pain medicines causes the brain's pain-suppression pathways to downregulate — the brain produces fewer of its own natural pain-dampening chemicals (endogenous opioids, serotonin) because it is relying on external medicines to do the job. When the medicine wears off, there is a "rebound" — the pain threshold drops, the head hurts, and the person takes more medicine. A vicious cycle forms: the medicine causes the headache that requires the medicine.

The triptans-MOH connection:

Triptans — sumatriptan, rizatriptan, naratriptan — cause MOH with use on as few as 10 days per month. Paradoxically, the more effective a triptan is at relieving an acute attack, the more it reinforces the cycle of use and rebound. Patients who say "my triptan always works but I need more and more of them" are often in early MOH.

What MOH looks like:

The counterintuitive treatment:

Breaking MOH requires stopping the overused medicine — often called "medication withdrawal" or "detoxification." This is genuinely difficult because the withdrawal phase (typically 2–4 weeks) produces severe rebound headache. Many patients cannot tolerate this without support. The good news is that after successful withdrawal, the headache pattern in most patients significantly improves — the brain's own pain regulation returns.

Who should manage MOH withdrawal:

This should be done under medical supervision. Abrupt withdrawal from opioids or barbiturates (Saridon contains butalbital in some formulations) can cause serious symptoms and requires careful management. NSAIDs and triptans can generally be stopped more abruptly, but medical support makes the process significantly easier.

Chronic migraine is a clinical diagnosis — it is made by history, not by a blood test or scan. However, there are important investigations to do and red flags that require urgent evaluation.

The headache diary — the most useful diagnostic tool:

Before any imaging or blood tests, a headache diary kept for at least 4 weeks provides invaluable information:

This diary tells a neurologist or homoeopathic physician more than any scan. It also reveals medication overuse patterns that the patient may not have recognised.

When brain imaging IS needed:

Not every patient with chronic migraine needs an MRI — but it is indicated if:

A normal MRI in a patient with long-standing, stable chronic migraine is completely expected. A normal scan does not mean "nothing is wrong" — it confirms that there is no structural cause, which is appropriate in chronic migraine.

Blood tests:

No specific blood test diagnoses migraine. However, thyroid function, complete blood count, and inflammatory markers are useful to rule out conditions that can cause or worsen headache — hypothyroidism, anaemia, and inflammatory conditions.

What is NOT needed:

Repeated CT scans, cervical spine MRI for every headache, expensive nerve conduction studies — these are frequently ordered but rarely helpful in evaluating chronic migraine. Radiation from repeated CT scans is a real concern and should be avoided unless a specific structural question needs answering.

Conventional preventive treatment for chronic migraine includes daily medicines taken specifically to reduce headache frequency. The commonly used options are:

Beta-blockers — propranolol, metoprolol. Work by stabilising cerebral blood vessel reactivity. Side effects: fatigue, reduced exercise tolerance, cold extremities, depression in susceptible individuals. Contraindicated in asthma.

Tricyclic antidepressants — amitriptyline (most used in India). Effective for both sleep improvement and migraine prevention. Side effects: morning sedation, weight gain, dry mouth, constipation. Can cause cardiac issues at higher doses.

Topiramate — an anticonvulsant used preventively. Shown to reduce migraine frequency. Side effects: cognitive slowing ("word-finding difficulty"), weight loss, kidney stones, not safe in pregnancy.

Venlafaxine — an SNRI antidepressant. Used when comorbid anxiety or depression is present. Side effects: nausea, sexual dysfunction, blood pressure changes.

CGRP monoclonal antibodies — erenumab, fremanezumab (newer, injectable). Specifically target the CGRP pathway involved in migraine. More targeted, fewer systemic side effects, expensive, monthly or quarterly injections.

Botulinum toxin (Botox) — injections every 12 weeks, approved specifically for chronic migraine (15+ headache days per month). Effective in a proportion of patients. Expensive, requires specialist administration.

The honest assessment:

These medicines reduce headache frequency in a proportion of patients — typically a 50% reduction in migraine days is the benchmark success. They do not cure chronic migraine. They require long-term daily use. When stopped, migraine often returns to pre-treatment levels. Side effects are real and affect adherence — many patients stop preventive medicines within 6 months because of how they feel. And they do not address MOH, the underlying sensitisation, or the root cause factors.

Chronic migraine presents a particular challenge to conventional medicine because the problem is not one episode — it is an entrenched state of nervous system sensitisation. Treating individual attacks once the system is chronically sensitised is like bailing out a boat without plugging the hole. Homoeopathy's constitutional approach works precisely at the level of this sensitisation — which is why it is genuinely well placed to address chronic migraine rather than just suppress individual attacks.

The constitutional approach in chronic migraine

A detailed homoeopathic case-taking for chronic migraine looks at the full picture — not just the headaches:

This level of individualization is what allows homoeopathy to prescribe at the constitutional level — treating the entire sensitised state, not just the headache.

Medicines that commonly feature in chronic migraine (always prescribed individually):

Natrum Muriaticum — one of the most frequently indicated medicines in chronic migraine. The typical picture includes a deep, recurrent migraine that feels like "hammers beating" inside the skull, often starting from the right side; worsening from consolation and from grief or suppressed emotions; the patient often has a history of suppressed feelings, reserved nature; migraine worse at 10 am, worse from sun exposure; may have visual symptoms; aversion to fat foods; craving salt.

Nux Vomica — chronic migraine in the "driven" personality — ambitious, perfectionist, easily irritated, overworked. Worse in the morning, worse from eating, worse from mental overwork. Often associated with digestive symptoms, constipation, coffee and alcohol sensitivity.

Sanguinaria Canadensis — a deep right-sided chronic migraine that starts from the back of the neck, extends to the right eye, with intense nausea and vomiting. Periodic — returns at regular intervals. Often hormonal in women.

Iris Versicolor — migraine with visual aura, intense burning, projectile vomiting. Often has a definite periodicity — every Sunday, or every few weeks at a specific time.

Sepia — chronic migraine in women with clear hormonal pattern; worse around periods; indifference, withdrawal, irritability; better from vigorous exercise; liver and digestive symptoms.

Glonoinum — bursting, throbbing headache, feels the head will burst; worse from sun; congestive quality.

Kali Phosphoricum — nervous exhaustion chronic migraine; headache from overwork, study, mental strain; person is easily startled, anxious, weary.

How MOH is managed in homoeopathy:

The constitutional approach works alongside the withdrawal from overused medicines — it does not replace the withdrawal. However, in our clinical experience, patients undergoing homoeopathic constitutional treatment find the withdrawal phase significantly easier — the nervous system is being supported at the root level, which reduces the severity of the rebound. The constitutional medicine also addresses the anxiety and stress that often drive the repeated medicine-seeking behaviour.

Realistic timeline for chronic migraine:

Chronic migraine that has been present for years requires patience. The initial improvement — typically in the 6–12 week range — is a reduction in the severity of headache days and the baseline head heaviness. Frequency reduction follows. Most patients who respond well achieve 50% or greater reduction in headache days within 4–6 months, with continued improvement over the following months. A return to episodic migraine, with clear pain-free windows, is the realistic treatment goal — not necessarily zero headaches, but a fundamental return to the episodic pattern.

One thing to be clear about: if a patient is in MOH with daily medicine use, the homoeopathic treatment cannot fully show its effects until the overused medicines are withdrawn. This is true of all preventive treatments, not just homoeopathy. Addressing MOH first — or simultaneously — is an essential part of treatment for chronic migraine with medication overuse.